These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 18997326)

  • 21. A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease.
    Dohnálek J; Hasek J; Dusková J; Petroková H; Hradilek M; Soucek M; Konvalinka J; Brynda J; Sedlácek J; Fábry M
    Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):472-6. PubMed ID: 11223536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling.
    Thanki N; Rao JK; Foundling SI; Howe WJ; Moon JB; Hui JO; Tomasselli AG; Heinrikson RL; Thaisrivongs S; Wlodawer A
    Protein Sci; 1992 Aug; 1(8):1061-72. PubMed ID: 1304383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir.
    Tie Y; Kovalevsky AY; Boross P; Wang YF; Ghosh AK; Tozser J; Harrison RW; Weber IT
    Proteins; 2007 Apr; 67(1):232-42. PubMed ID: 17243183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A neutron crystallographic analysis of phosphate-free ribonuclease A at 1.7 A resolution.
    Yagi D; Yamada T; Kurihara K; Ohnishi Y; Yamashita M; Tamada T; Tanaka I; Kuroki R; Niimura N
    Acta Crystallogr D Biol Crystallogr; 2009 Sep; 65(Pt 9):892-9. PubMed ID: 19690366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitor binding at the protein interface in crystals of a HIV-1 protease complex.
    Brynda J; Rezácová P; Fábry M; Horejsí M; Stouracová R; Soucek M; Hradílek M; Konvalinka J; Sedlácek J
    Acta Crystallogr D Biol Crystallogr; 2004 Nov; 60(Pt 11):1943-8. PubMed ID: 15502300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the structure of chemically synthesized HIV-1 protease complexed with a hexapeptide inhibitor. Part I: Crystallographic refinement of 2 A data.
    Miller M; Geller M; Gribskov M; Kent SB
    Proteins; 1997 Feb; 27(2):184-94. PubMed ID: 9061782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression, purification and preliminary X-ray crystallographic studies of the human immunodeficiency virus 1 subtype C protease.
    Coman RM; Robbins A; Goodenow MM; McKenna R; Dunn BM
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Apr; 63(Pt 4):320-3. PubMed ID: 17401206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid screening for HIV-1 protease inhibitor leads through X-ray diffraction.
    Pillai B; Kannan KK; Bhat SV; Hosur MV
    Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):594-6. PubMed ID: 14993705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
    Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
    Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Beginning of use of a new biological neutron diffractometer (iBIX) in J-PARC].
    Tanaka I; Kusaka K; Hosoya T; Ohhara T; Kurihara K; Niimura N
    Yakugaku Zasshi; 2010 May; 130(5):665-70. PubMed ID: 20460861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crystallization and preliminary neutron diffraction studies of ADP-ribose pyrophosphatase-I from Thermus thermophilus HB8.
    Okazaki N; Adachi M; Tamada T; Kurihara K; Ooga T; Kamiya N; Kuramitsu S; Kuroki R
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Jan; 68(Pt 1):49-52. PubMed ID: 22232170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein crystallization and initial neutron diffraction studies of the photosystem II subunit PsbO.
    Bommer M; Coates L; Dau H; Zouni A; Dobbek H
    Acta Crystallogr F Struct Biol Commun; 2017 Sep; 73(Pt 9):525-531. PubMed ID: 28876232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the structure of HIV-1 protease complexed with a hexapeptide inhibitor. Part II: Molecular dynamic studies of the active site region.
    Geller M; Miller M; Swanson SM; Maizel J
    Proteins; 1997 Feb; 27(2):195-203. PubMed ID: 9061783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutron crystallography used to identify targets to improve HIV-1 protease inhibitor.
    Hill R
    Future Med Chem; 2013 Oct; 5(15):1705. PubMed ID: 24144407
    [No Abstract]   [Full Text] [Related]  

  • 35. Structural role of the 30's loop in determining the ligand specificity of the human immunodeficiency virus protease.
    Swairjo MA; Towler EM; Debouck C; Abdel-Meguid SS
    Biochemistry; 1998 Aug; 37(31):10928-36. PubMed ID: 9692985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The three-dimensional x-ray crystal structure of HIV-1 protease complexed with a hydroxyethylene inhibitor.
    Graves BJ; Hatada MH; Miller JK; Graves MC; Roy S; Cook CM; Kröhn A; Martin JA; Roberts NA
    Adv Exp Med Biol; 1991; 306():455-60. PubMed ID: 1812742
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site.
    Skalova T; Dohnalek J; Duskova J; Petrokova H; Hradílek M; Soucek M; Konvalinka J; Hasek J
    J Med Chem; 2006 Sep; 49(19):5777-84. PubMed ID: 16970402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study.
    Skálová T; Hasek J; Dohnálek J; Petroková H; Buchtelová E; Dusková J; Soucek M; Majer P; Uhlíková T; Konvalinka J
    J Med Chem; 2003 Apr; 46(9):1636-44. PubMed ID: 12699382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Convergent chemical synthesis and crystal structure of a 203 amino acid "covalent dimer" HIV-1 protease enzyme molecule.
    Torbeev VY; Kent SB
    Angew Chem Int Ed Engl; 2007; 46(10):1667-70. PubMed ID: 17397076
    [No Abstract]   [Full Text] [Related]  

  • 40. Solution conformations of KNI-272, a tripeptide HIV protease inhibitor designed on the basis of substrate transition state: determined by NMR spectroscopy and simulated annealing calculations.
    Ohno Y; Kiso Y; Kobayashi Y
    Bioorg Med Chem; 1996 Sep; 4(9):1565-72. PubMed ID: 8894113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.